In this study, a novel small molecule compound, WG-391D, synthesized in our laboratory, was found to efficiently inhibit the expression, but not the catalytic dephosphorylation activity, of CDC25B in ovarian cancer cells. Here, CDC25B is linked to ovarian carcinoma.